NCT07408193 2026-02-20
The Role of Coadministration of Lidocaine and Ketamine in Opioid-Refractory Chronic Cancer-Related Pain.
National and Kapodistrian University of Athens
Phase EARLY_PHASE1 Not yet recruiting
Clinical Trials
12 trialsNCT02647385 2024-10-08
Pain Control in Breast Surgery: Analgesia, Opioid Consumption and Inflammatory Response Evaluation
Hospital Sirio-Libanes
Phase NA Active not recruiting
NCT04250805 2024-01-31
GASTROXY
Centre Hospitalier Universitaire de Saint Etienne
Phase 2 Terminated
NCT04703803 2023-04-25
Efficacy of Myofascial Pain Syndrome Treatment in Patients With Cancer in Palliative Care
University of Sao Paulo
Phase 3 Completed
NCT04741880 2021-07-30
ELSA
Instituto Nacional de Cancer, Brazil
Phase 2/3 Unknown
NCT03513757 2020-02-21
Dexmedetomidine and Propofol for Pediatric MRI Sedation
Medical College of Wisconsin
Phase 4 Completed
NCT01384877 2019-07-12
Subcutaneous Lidocaine For Cancer-Related Pain
British Columbia Cancer Agency
Phase 2/3 Completed
NCT02606994 2019-02-06
TPvsM
Oral Defense, LLC
Phase 2 Terminated
NCT02121951 2018-04-10
QLB
National Cancer Institute, Egypt
Phase 4 Withdrawn
NCT02137954 2015-08-28
LIDOSP
Assistance Publique Hopitaux De Marseille
Phase 3 Unknown
NCT00321347 2012-06-22
Intravenous (IV) Lidocaine for Opioid-refractory Pain
San Diego Hospice & Palliative Care
Phase 2 Withdrawn
NCT00181012 2007-09-19
Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Unknown